Pharming Group NV (PHARM) — Cash Flow Quality Index
Pharming Group NV (PHARM) has a Cash Flow Quality Index of 2.51x as of September 2025. Operating cash flow of €32.03 Million exceeds net income of €12.76 Million, indicating high earnings quality where cash backs reported profits. Explore Pharming Group NV (PHARM) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharming Group NV Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Pharming Group NV across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharming Group NV tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharming Group NV (2017–2022)
Year-by-year earnings quality comparison for Pharming Group NV. For live market cap and the full company financial profile, see PHARM stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.53x | €22.90 Million | €14.99 Million | ▼ -6.8% |
| 2021 | 1.64x | €36.13 Million | €22.03 Million | ▼ -14.5% |
| 2020 | 1.92x | €90.98 Million | €47.47 Million | ▲ +75.4% |
| 2019 | 1.09x | €74.56 Million | €68.23 Million | ▲ +2.8% |
| 2018 | 1.06x | €46.19 Million | €43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | €45.84 Million | €26.29 Million | — |